190 related articles for article (PubMed ID: 36268143)
1. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
Yang Y; Li X; Qian H; Di G; Zhou R; Dong Y; Chen W; Ren Q
Comput Intell Neurosci; 2022; 2022():6833078. PubMed ID: 36268143
[TBL] [Abstract][Full Text] [Related]
2. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
3. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
Zhang C; Yang Q
Front Oncol; 2020; 10():572203. PubMed ID: 33634012
[TBL] [Abstract][Full Text] [Related]
4. The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Han CL; Meng GX; Ding ZN; Dong ZR; Chen ZQ; Hong JG; Yan LJ; Liu H; Tian BW; Yang LS; Xue JS; Li T
Front Immunol; 2022; 13():827788. PubMed ID: 35211122
[TBL] [Abstract][Full Text] [Related]
5. Platelet-lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis.
Jiang S; Liu J; Chen X; Zheng X; Ruan J; Ye A; Zhang S; Zhang L; Kuang Z; Liu R
Arch Gynecol Obstet; 2019 Oct; 300(4):829-839. PubMed ID: 31385023
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
Zhang W; Zhang Z; Qian L
World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
[TBL] [Abstract][Full Text] [Related]
10. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
[TBL] [Abstract][Full Text] [Related]
11. Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients.
Sicking I; Edlund K; Wesbuer E; Weyer V; Battista MJ; Lebrecht A; Solbach C; Grinberg M; Lotz J; Hoffmann G; Rahnenführer J; Hengstler JG; Schmidt M
PLoS One; 2014; 9(10):e111306. PubMed ID: 25340395
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
Liu ZQ; Chu L; Fang JM; Zhang X; Zhao HX; Chen YJ; Xu Q
Asian J Androl; 2014; 16(3):467-71. PubMed ID: 24589465
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
15. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological impacts of Controlling Nutritional Status (CONUT) score on patients with gynecological cancer: a meta-analysis.
Niu Z; Yan B
Nutr J; 2023 Jul; 22(1):33. PubMed ID: 37422623
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
18. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
19. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Ethier JL; Desautels DN; Templeton AJ; Oza A; Amir E; Lheureux S
Gynecol Oncol; 2017 Jun; 145(3):584-594. PubMed ID: 28222899
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
